Antitumor activity of novel fluoro-substituted (–)-epigallocatechin-3-gallate analogs
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 292 (1) , 48-53
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Clinical development of novel proteasome inhibitors for cancer treatmentExpert Opinion on Investigational Drugs, 2009
- Multitargeted therapy of cancer by green tea polyphenolsCancer Letters, 2008
- Prodrugs of Fluoro-Substituted Benzoates of EGC as Tumor Cellular Proteasome Inhibitors and Apoptosis InducersInternational Journal of Molecular Sciences, 2008
- Methylation suppresses the proteasome‐inhibitory function of green tea polyphenolsJournal of Cellular Physiology, 2007
- A Novel Prodrug of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate as a Potential Anticancer AgentCancer Research, 2007
- The Tumor Proteasome Is a Primary Target for the Natural Anticancer Compound Withaferin A Isolated from “Indian Winter Cherry”Molecular Pharmacology, 2007
- Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cellsFrontiers in Bioscience-Landmark, 2005
- Protective effect of green tea against prostate cancer: A case‐control study in southeast ChinaInternational Journal of Cancer, 2003
- A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinomaCancer, 2003
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995